开发和评估食品动物的非抗生素增长促进剂
Hanfei Wang1, Hengji Zhao1, Bocheng Tai1
1National Reference Laboratory of Veterinary Drug Residues (HZAU), Veterinary Medicine Research Center, Huazhong Agricultural University, Wuhan 430070, China.
Veterinary sciences
|December 27, 2024
概括
从棘和木提取物中获得的新型植物性非抗生素增长促进剂 (NAGP) 显示出有前途. 这些NAGP增强动物的生长,肌肉发育和免疫力,为抗生素生长促进剂 (AGPs) 提供了替代品.
科学领域:
- 动物科学动物科学
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 抗生素增长促进剂 (AGPs) 在食用动物中广泛使用,但有助于抗生素耐药性.
- 对于有效的非抗生素增长促进剂 (NAGP) 来确保动物健康和食品安全至关重要.
研究的目的:
- 开发和评估植物衍生NAGP作为AGP的替代品.
- 在动物模型中研究这些新型化合物的增长促进机制.
主要方法:
- 在小鼠和肉中对促进生长的作用进行了实验,无论是体内还是体外.
- 开发并评估了一种优化的复合超能提取物M (CSEE-M) 对其对生长性能,料转化,消化酶,肠道微生物群和尸体质量的影响.
- 使用统计分析来确定显著性 (p < 0.05).
主要成果:
- 在小鼠中,SQ提取物显著增强肌肉生长和改善免疫力.
- CSEE-M显著改善了小鼠和肉的生长性能,料转化率和消化酶活性.
- 补充CSEE-M增加了肉的肌肉含量和改善了肉的尸体质量,同时也重塑了肠道微生物群.
结论:
- 无论是SQ还是CSEE-M都显示出作为有效的非抗生素增长促进剂的巨大潜力.
- 这些植物性化合物为抗生素增长促进剂提供了可行的替代品,解决了人们对抗生素耐药性的担忧.
相关概念视频
Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Toxicity Testing in Animals
204
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204


